Drug Creation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Creation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Creation Today - Breaking & Trending Today

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Published: May 28, 2024

VANCOUVER, Wash. and NEW YORK, May 28, 2024 -- Absci Corporation , a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs...

Source: marketscreener.com

Related Topics:

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Published: February 21, 2024

IND submission expected in Q1 2025; Phase 1 trials anticipated to initiate shortly afterVANCOUVER, Wash. and NEW YORK, Feb. 21, 2024 -- Absci Corporation , a data-first generative AI drug creation...

Source: marketscreener.com

Related Topics:

British Columbia New York United States Sean Mcclain Alex Khan Innovation Center Securities Exchange Exchange Commission Absci Corporation Nasdaq Ai Research Lab Drug Creation New York City Securities Act Securities Exchange Act

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Published: December 28, 2023

VANCOUVER, Wash. and NEW YORK, Dec. 28, 2023 -- Absci Corporation , a generative AI drug creation company, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan...

Source: marketscreener.com

Related Topics:

San Francisco United States British Columbia New York Alex Khan Absci Corporation Nasdaq Ai Research Lab Innovation Center Healthcare Conference Drug Creation New York City Securities Act

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

Published: December 4, 2023

Collaboration Combines Absci’s AI Antibody Drug Creation Platform with AstraZeneca’s Expertise in Oncology Research and DevelopmentVANCOUVER, Wash., Dec. 04, 2023 -- Absci Corporation , a...

Source: marketscreener.com